Latest Commercialisation News

Page 16 of 188
Wide Open Agriculture has agreed with Curtin University to replace its tiered royalty structure with a single 3.5% flat royalty on net sales, streamlining financial planning and enhancing commercial scalability for its lupin protein technology.
Ada Torres
Ada Torres
25 May 2026
TrivarX has contracted Beyond Drug Development to drive its Stabl-Im MRI imaging platform into Phase 1 trials, aiming to start safety testing in healthy volunteers by late 2026.
Ada Torres
Ada Torres
22 May 2026
Vitrafy Life Sciences has achieved a major validation milestone with US Army-backed Phase II results showing its no-wash platelet cryopreservation protocol delivers 94% post-thaw recovery, outperforming existing standards and advancing FDA registration plans.
Ada Torres
Ada Torres
22 May 2026
Findi Limited lowers its FY26 operating revenue and EBITDA guidance, citing integration costs and funding delays, but reports operational improvements following a $25 million equity raise and appoints a new Chief Commercial Officer.
Claire Turing
Claire Turing
21 May 2026
Papyrus Australia has fulfilled a critical contract milestone by delivering 200 biodegradable Collar Keeper product samples to TBS Mining Solutions, enabling the next phase of product testing despite a slight delay.
Victor Sage
Victor Sage
21 May 2026
AFT Pharmaceuticals posted a 22% revenue jump to NZ$254.7 million and a 39% increase in operating profit to a record NZ$24.4 million for FY26, exceeding guidance. The company targets over NZ$300 million revenue for FY27, fueled by international expansion and a deepening R&D pipeline.
Ada Torres
Ada Torres
21 May 2026
Gold Hydrogen is accelerating Helium development at its Ramsay Project, leveraging exceptional purity results and independent modelling amid a tightening global Helium supply.
Maxwell Dee
Maxwell Dee
20 May 2026
Cleo Diagnostics has laid out a clear U.S. reimbursement pathway for its ovarian cancer test, leveraging an existing CPT code to enable early market entry and data collection ahead of FDA clearance.
Ada Torres
Ada Torres
20 May 2026
OncoSil Medical has clinched TGA approval for its OncoSil™ device, the first Class III medical device targeting pancreatic tumours in Australia, paving the way for local commercialisation and enhanced patient access.
Ada Torres
Ada Torres
20 May 2026
ION Video has appointed former Apple executive Kelli Richards as its inaugural Advisory Board member, aiming to leverage her Silicon Valley connections and media tech expertise to accelerate commercialisation.
Sophie Babbage
Sophie Babbage
20 May 2026
88 Energy is gearing up to drill its Augusta-1 exploration well in Alaska’s North Slope, targeting a stacked oil resource estimated at 133.7 million barrels gross unrisked. The company has secured key operational assets and is progressing farm-out talks to share drilling risks ahead of the planned Q1 2027 spud.
Maxwell Dee
Maxwell Dee
20 May 2026
Fulcrum Lithium’s latest metallurgical tests at Alkali Flats reveal lithium recovery rates exceeding 90% with promising low-temperature, short-duration leaching methods, expanding processing flexibility ahead of Phase 3 core analysis.
Maxwell Dee
Maxwell Dee
19 May 2026